Pulmonary Rehabilitation as a Mechanism to Reduce Hospitalizations for Acute Exacerbations of COPD A Systematic Review and Meta-Analysis

被引:51
|
作者
Moore, Elizabeth [1 ]
Palmer, Thomas [2 ]
Newson, Roger [2 ]
Majeed, Azeem [2 ]
Quint, Jennifer K. [1 ]
Soljak, Michael A. [2 ]
机构
[1] Imperial Coll London, Dept Resp Epidemiol Occupat Med & Publ Hlth, London, England
[2] Imperial Coll London, Dept Primary Care & Pubic Hlth, London, England
关键词
COPD; exacerbations; hospitalizations; pulmonary; rehabilitation; HEALTH-CARE UTILIZATION; DISEASE; PROGRAM; EFFICACY;
D O I
10.1016/j.chest.2016.05.038
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Acute exacerbation of COPD (AECOPD) has a significant impact on health-care use, including physician visits and hospitalizations. Previous studies and reviews have shown that pulmonary rehabilitation (PR) has many benefits, but the effect on hospitalizations for AECOPD is inconclusive. METHODS: A literature search was carried out to find studies that might help determine, using a meta-analysis, the impact of PR on AECOPD, defined as unscheduled or emergency hospitalizations and ED visits. Cohort studies and randomized controlled trials (RCTs) reporting hospitalizations for AECOPD as an outcome were included. Meta-analyses compared hospitalization rates between eligible PR recipients and nonrecipients before and after rehabilitation. RESULTS: Eighteen studies were included in the meta-analysis. Results from 10 RCTs showed that the control groups had a higher overall rate of hospitalization than did the PR groups (control groups: 0.97 hospitalizations/patient-year; 95% CI, 0.67-1.40; PR groups: 0.62 hospitalizations/patient-year; 95% CI, 0.33-1.16). Five studies compared admission numbers in the 12 months before and after rehabilitation, finding a significantly higher admission rate before compared with after (before: 1.24 hospitalizations/patient-year; 95% CI, 0.66-2.34; after: 0.47 hospitalizations/patient-year; 95% CI, 0.28-0.79). The pooled result of three cohort studies found that the reference group had a lower admission rate compared with the PR group (0.18 hospitalizations/patient-year; 95% CI, 0.11-0.32 for reference group vs 0.28 hospitalizations/patient-year; 95% CI, 0.25-0.32 for the PR group). CONCLUSIONS: Although results from RCTs suggested that PR reduces subsequent admissions, pooled results from the cohort studies did not, likely reflecting the heterogeneous nature of individuals included in observational research and the varying standard of PR programs.
引用
收藏
页码:837 / 859
页数:23
相关论文
共 50 条
  • [31] Blood eosinophilia as predictor for outcomes in COPD exacerbations: a systematic review and meta-analysis
    Villalobos, Ralph Elvi
    David-Wang, Aileen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [32] Pharmacological management to reduce exacerbations in adults with asthma - A systematic review and meta-analysis
    Sin, DD
    Man, J
    Sharpe, H
    Gan, WQ
    Man, SFP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03): : 367 - 376
  • [33] Pulmonary rehabilitation for pneumoconiosis: protocol for a systematic review and meta-analysis
    Zhao, Hulei
    Xie, Yang
    Wang, Jiajia
    Li, Xuanlin
    Li, Jiansheng
    [J]. BMJ OPEN, 2019, 9 (08):
  • [34] Effectiveness of pulmonary rehabilitation in elderly patients with COPD: A systematic review and meta-analysis of randomized controlled trials
    Li, Weitong
    Pu, Yalou
    Meng, Aifeng
    Zhi, Xiaoxu
    Xu, Guihua
    [J]. INTERNATIONAL JOURNAL OF NURSING PRACTICE, 2019, 25 (05)
  • [35] Benefits from Incorporating Virtual Reality in Pulmonary Rehabilitation of COPD Patients: A Systematic Review and Meta-Analysis
    Patsaki, Irini
    Avgeri, Vasiliki
    Rigoulia, Theodora
    Zekis, Theodoros
    Koumantakis, George A.
    Grammatopoulou, Eirini
    [J]. ADVANCES IN RESPIRATORY MEDICINE, 2023, 91 (04) : 324 - 336
  • [36] Update on the Clinical Effect of Prophylactic Antibiotic Treatment for Acute Exacerbations in Patients with COPD: Systematic Review and Meta-Analysis
    Wang, Yuanyuan
    Zijp, Tanja
    Hak, Eelko
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 367 - 367
  • [37] Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Pitre, Tyler
    Lupas, Daniel
    Ebeido, Ibrahim
    Colak, Alexander
    Modi, Mihir
    V. Kachkovski, George
    Montesi, Sydney B.
    Khor, Yet H.
    Kawano-Dourado, Leticia
    Jenkins, Gisli
    Fisher, Jolene H.
    Shapera, Shane
    Rochwerg, Bram
    Couban, Rachel
    Zeraatkar, Dena
    [J]. RESPIRATORY MEDICINE, 2024, 222
  • [38] Endothelial Dysfunction during Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
    Theodorakopoulou, Marieta P.
    Bakaloudi, Dimitra Rafailia
    Alexandrou, Maria Eleni
    Papakosta, Despoina
    Pataka, Athanasia
    Kioumis, Ioannis
    Boutou, Afroditi K.
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 18 (02) : 246 - 253
  • [39] Medication adherence to inhalation therapy and the risk of COPD exacerbations: a systematic review with meta-analysis
    Vauterin, Delphine
    Van Vaerenbergh, Frauke
    Grymonprez, Maxim
    Vanoverschelde, Anna
    Lahousse, Lies
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [40] BLOOD EOSINOPHILIA AS PREDICTOR FOR PATIENT OUTCOMES IN COPD EXACERBATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Villalobos, R. E.
    Magallanes, J.
    David-Wang, A.
    [J]. THORAX, 2016, 71 : A160 - A160